Trending Topic

Illustration of the thought processes in the brain
13 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The prevalence of unruptured intracranial aneurysms (IAs) is approximately 3% of the population, with incidence on the rise due to the increased utilization of neuro-imaging for diverse objectives.1,2 The average risk of rupture for unruptured IA is estimated to vary from 0.3% to exceeding 15% per 5 years.3 Ruptured IA is the primary aetiology of […]

Huntington Potter, AD/PD 2022: Sargramostim, a potential role in the treatment of Alzheimer’s disease: Phase 2 Results

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 25th 2022

Sargramostim, an innate immune system modulator, has been FDA approved for treating leukopenia for many years. Sargramostim has been investigated in this phase 2 study to determine if it can safely halt or reduce cognitive decline and brain pathology in participants with mild-to-moderate Alzheimer’s disease.

Prof. Huntington Potter (University of Colorado, Denver, MS, USA) joins touchNEUROLOGY to discuss the phase 2 results (NCT01409915) to investigate whether  inflammation and the innate immune system in Alzheimer’s disease may provide therapeutic benefit, and what will be the next steps in the development of sargramostim in Alzheimer’s disease.

Questions:

  1. Could you tell us a little about sargramostim, its mechanism of action and clinical uses? (0:18)
  2. What is the rationale for investigating sargramostim in the setting of Alzheimer’s disease (AD)? (1:15)
  3. What were the aims, design and primary outcome measures of your study? (3:25)
  4. What will be the next step in the clinical development of sargramostim in AD? (5:52)
  5. What are the take home messages from your presentation? (7:58)

Disclosures: Huntington Potter has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch

Filmed as a highlight of AD/PD 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup